Option Care Health (NASDAQ:OPCH) Downgraded to “Hold” Rating by Wall Street Zen

Wall Street Zen cut shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a hold rating in a research report sent to investors on Saturday.

Several other research firms have also issued reports on OPCH. Jefferies Financial Group reissued a “buy” rating and set a $37.00 price target on shares of Option Care Health in a report on Tuesday, January 13th. Stephens raised Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Barrington Research boosted their price objective on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, December 9th. Finally, Citizens Jmp reiterated a “market outperform” rating and issued a $38.00 price target (up from $36.00) on shares of Option Care Health in a research report on Tuesday, January 13th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and an average price target of $37.58.

Option Care Health Stock Up 1.8%

Shares of OPCH stock opened at $32.46 on Friday. The company has a current ratio of 1.53, a quick ratio of 1.05 and a debt-to-equity ratio of 0.87. Option Care Health has a 12 month low of $24.24 and a 12 month high of $36.80. The stock has a market cap of $5.08 billion, a P/E ratio of 25.36, a P/E/G ratio of 1.88 and a beta of 0.84. The company has a 50 day simple moving average of $33.99 and a two-hundred day simple moving average of $30.59.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The business had revenue of $1.47 billion for the quarter, compared to analysts’ expectations of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company’s revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.44 EPS. On average, research analysts expect that Option Care Health will post 1.22 earnings per share for the current year.

Hedge Funds Weigh In On Option Care Health

Several institutional investors have recently bought and sold shares of OPCH. V Square Quantitative Management LLC purchased a new stake in Option Care Health in the 4th quarter worth $25,000. Cornerstone Planning Group LLC grew its position in shares of Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after purchasing an additional 1,067 shares in the last quarter. Advisory Services Network LLC bought a new stake in shares of Option Care Health in the third quarter worth about $35,000. McIlrath & Eck LLC purchased a new stake in shares of Option Care Health in the second quarter worth about $37,000. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in shares of Option Care Health in the third quarter worth about $38,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.